美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Definium Therapeutics

43.27

-1.6400-3.65%

盤後：43.270.00000.00%16:04 EDT

成交量：172.00萬

成交額：7,422.48萬

市值：58.14億

市盈率：-12.43

高：44.46

開：44.46

低：41.25

收：44.91

52周最高：49.70

52周最低：8.70

股本：1.34億

流通股本：1.31億

量比：0.95

換手率：1.31%

股息：- -

股息率：- -

每股收益(TTM):-3.4823

每股收益(LYR):-2.0600

淨資產收益率：-64.09%

總資產收益率：-20.64%

市淨率：6.33

市盈率(LYR):-21.00

資料載入中...

總覽公司新聞資訊公告

市場快訊——美股行情動態-Sutro Biopharma、Humacyte

Definium Therapeutics 焦慮症藥物晚期試驗達標，盤前股價飆升 22%

Definium Therapeutics股價上漲，因其治療焦慮症的藥物達到了後期臨床試驗的目標

Definium Therapeutics 宣佈DT120 Odt針對廣泛性焦慮障礙的3期Voyage研究取得積極頂線結果

Definium Therapeutics：DT120 Odt 三期Voyage研究達成主要及關鍵次要療效終點

Definium公司表示，基於LSD的藥片在晚期臨床試驗中可緩解焦慮

Definium Therapeutics：DT120 Odt 在研究中總體耐受性良好，未出現包括自殺傾向信號在內的新安全性信號

Definium Therapeutics：DT120 Odt 受試者漢密爾頓焦慮量表評分實現統計學顯著降低

美國研究綜述-德克爾斯品牌、羅林斯、聯合租賃

異動解讀｜Definium Therapeutics盤中上漲5.14%，報45.0美元

異動解讀｜Definium Therapeutics盤中上漲5.5%，DT120三期數據利好疊加行業併購催化

Definium Therapeutics 啓動「焦慮之源」計劃，攜手醫療提供者深化廣泛性焦慮症患者影響及神經生物學認知

異動解讀｜Definium Therapeutics盤前上漲5.1%，DT120三期數據利好持續發酵

異動解讀｜Definium Therapeutics夜盤上漲7.03%，DT120三期數據利好持續發酵

異動解讀｜Definium Therapeutics盤後上漲5.04%，報47.79美元

異動解讀｜Definium Therapeutics盤中上漲5.13%，報45.89美元

異動解讀｜Definium Therapeutics盤中下跌5.44%，報44.47美元

異動解讀｜Definium Therapeutics盤中下跌5.06%，報46.0美元

異動解讀｜Definium Therapeutics盤中上漲5.09%，DT120三期臨床成功疊加鉅額融資提振市場信心

異動解讀｜Definium Therapeutics盤中下跌5.02%，報44.68美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/DFTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":43.27,"timestamp":1787601600000,"preClose":44.91,"halted":0,"volume":1719966,"hourTrading":{"tag":"盘后","latestPrice":43.27,"preClose":43.27,"latestTime":"16:04 EDT","volume":22887,"amount":990320.4900000001,"timestamp":1787601856658,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.036517479403250806,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"盤後交易","change":-1.64,"latestTime":"08-24 16:08:31 EDT","open":44.46,"high":44.46,"low":41.25,"amount":74224753,"amplitude":0.071476,"askPrice":44.13,"askSize":45,"bidPrice":42.01,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":44.91,"preHourTrading":{"tag":"盘前","latestPrice":44.53,"preClose":44.91,"latestTime":"09:29 EDT","volume":2695,"amount":120581.846,"timestamp":1787578170124,"change":-0.38,"changeRate":-0.008461,"amplitude":0.024271},"postHourTrading":{"tag":"盘后","latestPrice":43.27,"preClose":43.27,"latestTime":"16:04 EDT","volume":22887,"amount":990320.4900000001,"timestamp":1787601856658,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.949995,"optionData":{"bulkOrders":[{"symbol":"DFTX","call":true,"expireDate":1792123200000,"strike":"45.0","timestamp":1787579284670,"price":4.6,"volume":2000,"amount":920000,"type":"-"}]},"impliedVol":0.8272,"impliedVolPercentile":0.2649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.949995,"shares":134366950,"dividePrice":0,"high":44.46,"amplitude":0.071476,"preClose":44.91,"low":41.25,"week52Low":8.7,"pbRate":"6.33","week52High":49.7,"institutionHeld":0,"latestPrice":43.27,"committee":-0.8,"eps":-3.482311,"divideRate":0,"volume":1719966,"delay":0,"ttmEps":-3.482311,"open":44.46,"prevYearClose":13.39,"prevWeekClose":44.91,"prevMonthClose":43.52,"prevQuarterClose":47.04,"fiveDayClose":45.26,"twentyDayClose":42.65,"sixtyDayClose":23.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-08-21","current":-12.425656,"percent":0.221477,"low":-27.074722,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"high":-8.802064,"avg":-13.793358,"sd":5.619462,"marketCap":6100259530},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530}],"updateTime":1787602111758},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659909279","title":"市場快訊——美股行情動態-Sutro Biopharma、Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2659909279","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659909279?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 00:18","pubTimestamp":1786551516,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI持平于53,793.87点。标普500指数.SPX上涨0.22%，报7,745.57点；纳斯达克综合指数.IXIC上涨0.47%，报26,569.32点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4T4491DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UFO","SMWB","LAZR","BETA","OPLN","TSHA","CHTR","ABSI","SMMT","STRO","DFTX","CRWV","BIVI","ANNX","NBIX","NBIS","SRHR","GAP","CAVA","NCMI","SLXN","CIEN","OFAL","LQDA","HUMA","FSLR","UAMY","NTHI","SVV","TRMB","PFGC","RSPG","TECH","WXM","DPRE","SLN","LITE","ALT","EROC","EAT","HRB","LUMA","O","SLNCF","FRNW","NBIL","LITX","LOCL","TPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192985516","title":"Definium Therapeutics 焦慮症藥物晚期試驗達標，盤前股價飆升 22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192985516","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192985516?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:45","pubTimestamp":1786535108,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 的股价在盘前交易时段猛涨22%，原因在于该公司针对焦虑症的一款药物成功达成了后期临床试验的核心目标。这一喜讯瞬间点燃了市场热情，投资者纷纷涌入，推动股价大幅上扬。此次试验结果无疑为这家生物技术公司注入了强劲的发展动力，也为其在精神健康领域的布局增添了关键砝码。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658744709","title":"Definium Therapeutics股價上漲，因其治療焦慮症的藥物達到了後期臨床試驗的目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2658744709","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658744709?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:43","pubTimestamp":1786535004,"startTime":"0","endTime":"0","summary":"BUZZ-Definium Therapeutics股价上涨，因其治疗焦虑症的药物达到了后期临床试验的目标8月12日-** 生物技术公司 Definium Therapeutics（DFTX.O）的股价在盘前交易中上涨 22.2%，至 50.01 美元** 该公司 (link) 表示，在一项晚期临床研究中，其基于LSD的实验性口服药显著减轻了广泛性焦虑障碍（GAD）成年患者的焦虑症状，达到了试验的","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4490US:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0123","BK0010","BK4007","BK0188","600776","BK0012","BK0214","BK0090","BK0028","BK0167","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143492874","title":"Definium Therapeutics 宣佈DT120 Odt針對廣泛性焦慮障礙的3期Voyage研究取得積極頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1143492874","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143492874?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:01","pubTimestamp":1786532478,"startTime":"0","endTime":"0","summary":"Definium Therapeutics（DFTX）今日发布重磅消息：其针对广泛性焦虑障碍的DT120 Odt，在3期Voyage研究中录得积极的顶线数据。该研究结果令人振奋，为这款在研疗法带来了新曙光。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168532165","title":"Definium Therapeutics：DT120 Odt 三期Voyage研究達成主要及關鍵次要療效終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1168532165","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168532165?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:01","pubTimestamp":1786532471,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，其关键药物DT120 Odt的三期临床试验Voyage研究已成功达成主要及关键次要疗效终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971366","title":"Definium公司表示，基於LSD的藥片在晚期臨床試驗中可緩解焦慮","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971366","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971366?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532446,"startTime":"0","endTime":"0","summary":"Definium公司表示，基于LSD的药片在晚期临床试验中可缓解焦虑路透8月12日-Definium Therapeutics公司周三表示，其基于LSD的实验性药片在一项晚期研究中显著减轻了焦虑症状，达到了试验的主要目标。该公司表示，经安慰剂校正后的5.4分差异在统计学上显著且具有临床意义。监管机构 以及投资者对迷幻类疗法的热情 ，推动Definium股价今年迄今已上涨逾三倍。此次试验是Definium公司针对DT120取得的第二项晚期临床试验成功，此前该公司在6月公布了一项抑郁症研究的积极结果 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4T4490RK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103074392","title":"Definium Therapeutics：DT120 Odt 在研究中總體耐受性良好，未出現包括自殺傾向信號在內的新安全性信號","url":"https://stock-news.laohu8.com/highlight/detail?id=1103074392","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103074392?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532410,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 宣布，其药物 DT120 Odt 在一项临床研究中展现出总体良好的耐受性。研究未发现任何新的安全性信号，其中尤为关键的是，没有监测到自杀倾向相关的信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159415209","title":"Definium Therapeutics：DT120 Odt 受試者漢密爾頓焦慮量表評分實現統計學顯著降低","url":"https://stock-news.laohu8.com/highlight/detail?id=1159415209","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159415209?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532409,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 宣布，其药物 DT120 Odt 在临床试验中取得突破性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653704896","title":"美國研究綜述-德克爾斯品牌、羅林斯、聯合租賃","url":"https://stock-news.laohu8.com/highlight/detail?id=2653704896","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653704896?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 15:16","pubTimestamp":1784877371,"startTime":"0","endTime":"0","summary":"美国研究综述-德克尔斯品牌、罗林斯、联合租赁路透7月24日-周五，华尔街证券分析师修订了多家在美国上市公司的评级和目标价，其中包括德克斯品牌、罗林斯和联合租赁。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4S43Q0I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FCXG","AMDL","CTSH","BMED","DECK","LMT","MBWM","URI","DOW","CNAV","LOB","ACI","PKG","DAMD","DOV","NSC","AAL","NVR","NIC","MPLT","AMP","OBK","SAM","CMCSA","ALK","AMD","FCX","INTC","FOA","JUP.UK","PSCH","ROL","BX","THRM","KRMN","MEDP","EW","HON","BPOP","TEK","PNFP","FCNCA","DOMO","DFTX","MOH","LRCX","R","NDAQ","AMAT","IDEF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133954038","title":"異動解讀｜Definium Therapeutics盤中上漲5.14%，報45.0美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133954038","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133954038?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 03:49","pubTimestamp":1784663380,"startTime":"0","endTime":"0","summary":"7月22日，Definium Therapeutics盘中上涨5.14%，报45.0美元/股，成交额3936.95万美元。Definium Therapeutics所在的制药行业中，个股中，礼来涨1.95%，强生涨0.65%，默沙东涨1.46%，惠普森医药涨853.85%，辉瑞涨0.63%。Definium Therapeutics是一家处于后期阶段的临床生物制药公司，正在开发新的候选产品来治疗大脑健康障碍。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105069526","title":"異動解讀｜Definium Therapeutics盤中上漲5.5%，DT120三期數據利好疊加行業併購催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1105069526","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105069526?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 21:42","pubTimestamp":1784209375,"startTime":"0","endTime":"0","summary":"7月16日，Definium Therapeutics盘中上涨5.5%，报46.68美元/股，成交额2316.68万美元。消息面上，公司核心候选药物DT120口崩片治疗重度抑郁症的3期EMERGE研究此前取得积极顶线结果，主要终点及所有关键次要疗效终点均达成。随后公司成功完成8.05亿美元增发募资，承销商全额行使超额配售权。RBC Capital将目标价从36美元大幅上调至57美元，维持\"跑赢大盘\"评级，当前股价仍低于该目标价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Definium Therapeutics盘中上涨5.5%，DT120三期数据利好叠加行业并购催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113882972","title":"Definium Therapeutics 啓動「焦慮之源」計劃，攜手醫療提供者深化廣泛性焦慮症患者影響及神經生物學認知","url":"https://stock-news.laohu8.com/highlight/detail?id=1113882972","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113882972?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 19:01","pubTimestamp":1784199702,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 宣布启动一项名为“焦虑之源”的医疗提供者倡议。该计划旨在推动医学界对广泛性焦虑症（GAD）患者所面临的影响及其背后神经生物学机制的理解，以期促进更有效的临床诊疗策略发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182980299","title":"異動解讀｜Definium Therapeutics盤前上漲5.1%，DT120三期數據利好持續發酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1182980299","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182980299?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 16:46","pubTimestamp":1784191619,"startTime":"0","endTime":"0","summary":"7月16日，Definium Therapeutics盘前上涨5.1%，报48.0美元/股，成交额6.29万美元。随后公司成功完成8.05亿美元增发募资，承销商全额行使超额配售权，募资用于DT120商业化准备及研发推进。RBC Capital将目标价从36美元大幅上调至57美元，维持\"跑赢大盘\"评级，当前股价仍低于该目标价，市场买盘动能延续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Definium Therapeutics盘前上涨5.1%，DT120三期数据利好持续发酵","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154657006","title":"異動解讀｜Definium Therapeutics夜盤上漲7.03%，DT120三期數據利好持續發酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1154657006","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154657006?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 08:47","pubTimestamp":1784162870,"startTime":"0","endTime":"0","summary":"7月16日，Definium Therapeutics夜盘上涨7.03%，报48.87美元/股，成交额1.91万美元。消息面上，公司此前公布其核心候选药物DT120口崩片治疗重度抑郁症的3期EMERGE研究取得积极顶线结果，主要终点及所有关键次要疗效终点均达成，显示出统计学显著性和临床意义的优势。随后公司成功完成8.05亿美元增发募资，承销商全额行使超额配售权。RBC Capital将目标价从36美元大幅上调至57美元，维持\"跑赢大盘\"评级，当前股价仍低于该目标价，市场买盘动能延续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127959646","title":"異動解讀｜Definium Therapeutics盤後上漲5.04%，報47.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127959646","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127959646?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 06:57","pubTimestamp":1784156250,"startTime":"0","endTime":"0","summary":"7月16日，Definium Therapeutics盘后上涨5.04%，报47.79美元/股，成交额141.84万美元。Definium Therapeutics所在的制药行业中，个股中，礼来涨0.03%，强生涨0.36%，默沙东涨0.02%，辉瑞跌0.12%，施贵宝跌0.0%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159498308","title":"異動解讀｜Definium Therapeutics盤中上漲5.13%，報45.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159498308","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159498308?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 00:37","pubTimestamp":1784047070,"startTime":"0","endTime":"0","summary":"7月15日，Definium Therapeutics盘中上涨5.13%，报45.89美元/股，成交额2377.21万美元。Definium Therapeutics所在的制药行业中，个股中，礼来跌2.64%，强生跌1.89%，默沙东跌2.93%，辉瑞跌1.04%，阿斯利康跌2.14%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111295043","title":"異動解讀｜Definium Therapeutics盤中下跌5.44%，報44.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111295043","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111295043?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 22:21","pubTimestamp":1783952499,"startTime":"0","endTime":"0","summary":"7月13日，Definium Therapeutics盘中下跌5.44%，报44.47美元/股，成交额1282.29万美元。Definium Therapeutics所在的制药行业中，个股中，礼来跌0.21%，辉瑞涨1.78%，强生涨0.03%，Crinetics Pharmaceuticals涨0.06%，阿斯利康跌1.47%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142071966","title":"異動解讀｜Definium Therapeutics盤中下跌5.06%，報46.0美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142071966","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142071966?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 21:51","pubTimestamp":1783691501,"startTime":"0","endTime":"0","summary":"7月10日，Definium Therapeutics盘中下跌5.06%，报46.0美元/股，成交额912.92万美元。Definium Therapeutics所在的制药行业中，个股中，礼来跌2.01%，强生涨0.17%，阿斯利康跌2.55%，Crinetics Pharmaceuticals涨0.05%，默沙东跌0.42%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143979950","title":"異動解讀｜Definium Therapeutics盤中上漲5.09%，DT120三期臨床成功疊加鉅額融資提振市場信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1143979950","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143979950?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 23:53","pubTimestamp":1783612422,"startTime":"0","endTime":"0","summary":"7月9日，Definium Therapeutics盘中上涨5.09%，报47.625美元/股，成交额6690.95万美元。消息面上，公司此前公布其核心产品DT120口崩片治疗重度抑郁症的3期EMERGE研究取得积极顶线结果，达到主要终点及所有关键次要疗效终点，安全性特征良好。RBC Capital随之将目标价由36美元大幅上调至57美元，维持\"跑赢大市\"评级。关键临床数据验证叠加充裕资金保障，持续推动股价上行。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137042231","title":"異動解讀｜Definium Therapeutics盤中下跌5.02%，報44.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137042231","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137042231?lang=zh_tw&edition=fundamental","pubTime":"2026-07-01 23:49","pubTimestamp":1782920992,"startTime":"0","endTime":"0","summary":"7月1日，Definium Therapeutics盘中下跌5.02%，报44.68美元/股，成交额4259.27万美元。Definium Therapeutics所在的制药行业中，个股中，礼来跌0.61%，强生跌0.66%，辉瑞跌0.69%，默沙东跌1.49%，诺和诺德涨2.69%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}